Impact of reimbursement policies on prudent use, availabillity and - - PowerPoint PPT Presentation

Impact of reimbursement policies on prudent use, availabillity and pipeline of new antibacterials

Ad Schuurman London, 8th November

2

Quick review

• Short interviews 26 EU countries
• Competent Authorities
• Departments of Health
• Reimbursement organisations (assessment and payers)
• Actual, but not scientific

3

Results

• 20 have no reimbursement policies
• 4 (?) trust on doctors guidelines (some monitor doctor prescribing)
• 20 follow normal reimbursement procedures for AMB’s
• 2 special committee has to approve reimbursement AMB (high

price)

• 1 uses co payment
• 1 essential list AMB
• 10 committee rational use (information, monitoring,

recommendation treatment

• 2(?) promote innovation/ investment
• 2 campagne to population

4

General aspects

• In patient: hospital policy (not transparent)
• Out patient: committees
• Veterinary system can be dangerous